LW
ARKG icon

Lauer Wealth’s ARK Genomic Revolution ETF ARKG Stock Holding History

Lauer Wealth’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-48,218
Closed -$694K – 67
2025
Q2 		$694K Buy
+48,218
New +$1.06M 0.57% 22

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Lauer Wealth's ARKG Position: Q2 2026 in Review

Lauer Wealth reduced its ARK Genomic Revolution ETF (ARKG) stake by 22% in Q2 2026, selling an estimated $159K and leaving 17,643 shares worth $724K. The position accounts for 0.43% of the portfolio, ranked #34.

Lauer Wealth first reported a position in ARKG in Q1 2025 and has held it in 5 quarters since. The position peaked at $730K in Q3 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Lauer Wealth held 17,643 shares of ARK Genomic Revolution ETF worth $724K as of Q2 2026.
  • Lauer Wealth sold 5,000 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $159K.
  • ARK Genomic Revolution ETF made up 0.43% of Lauer Wealth's portfolio in Q2 2026, its #34 holding.
  • Lauer Wealth first reported a position in ARK Genomic Revolution ETF in Q1 2025 and has held it in 5 quarters since.
  • Lauer Wealth's ARK Genomic Revolution ETF position peaked at $730K in Q3 2025.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Lauer Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.